These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5677577)

  • 1. Some hematologic differences between thromboangiitis obliterans and atherosclerosis.
    Craven JL; Cotton RC
    Angiology; 1968 Sep; 19(8):450-9. PubMed ID: 5677577
    [No Abstract]   [Full Text] [Related]  

  • 2. Haematological differences between thromboangiitis obliterans and atherosclerosis.
    Craven JL; Cotton RC
    Br J Surg; 1967 Oct; 54(10):862-7. PubMed ID: 6047270
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated serum urate and normocholesterolemia in patients with thromboangiitis obliterans.
    Giler S; Urca I; Sperling O
    Biomedicine; 1978 May; 29(3):86-7. PubMed ID: 687750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and experimental studies on fibrinolysis activation].
    Bielawiec M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1967; 15():1-92. PubMed ID: 4953138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pro and con: etiology of arteriosclerosis. Essential significance of circulating blood, especially of thrombocytes and the blood coagulation and fibrinolysis systems].
    Hess H
    Internist (Berl); 1981 Nov; 22(11):658-60. PubMed ID: 7031003
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum zinc and copper in patients with atherosclerosis and thromboangiitis obliterans.
    Uza G; Vlaicu R
    Biol Trace Elem Res; 1989 Jun; 20(3):197-206. PubMed ID: 2484753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the blood coagulation system in obliterating diseases of the arteries of the extremities].
    Krastin OA
    Sov Med; 1971 Apr; 34(4):65-9. PubMed ID: 5143757
    [No Abstract]   [Full Text] [Related]  

  • 8. [Variability of blood lipoprotein spectrum after injections of small doses of heparin].
    SZAJEWSKI J
    Pol Arch Med Wewn; 1958; 28(5):702-5. PubMed ID: 13601310
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood nucleotides in patients with peripheral vascular disease.
    Vlaicu R; Stef C; Uza G; Cucuianu M
    Med Interne; 1979; 17(3):241-3. PubMed ID: 504928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum lipids and lipoproteins in peripheral vascular disease].
    Umemoto T
    Nihon Geka Gakkai Zasshi; 1985 Jan; 86(1):84-97. PubMed ID: 3974570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of serum lipoprotein(a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans.
    Takami S; Kubo M; Yamashita S; Kameda-Takemura K; Kawasaki T; Kanbayashi J; Nakamura Y; Yokoi Y; Ohnishi K; Matsuzawa Y
    Atherosclerosis; 1995 Jan; 112(2):253-60. PubMed ID: 7772084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased level of plasma factor VIII-related antigen in peripheral arterial disease.
    Uza G; Opincaru N; Cristea A; Rus HG; Cucuianu M
    Med Interne; 1985; 23(3):171-5. PubMed ID: 3931204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood protein picture in arterial diseases of the legs].
    PEZZUOLI G; MONTORSI W; GHIRINGHELLI C; GALLO G
    Angiologia; 1955; 7(2):54-66. PubMed ID: 14376917
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombosis in various diseases: vascular surgery].
    Mishima Y
    Nihon Rinsho; 1986 May; 44(5):1187-93. PubMed ID: 3528578
    [No Abstract]   [Full Text] [Related]  

  • 15. [ANTICOAGULATION ACTIVITY OF HEPARIN IN THE BLOOD OF PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE BLOOD VESSELS OF THE LOWER EXTREMITIES].
    DEKHTIAR AL
    Klin Med (Mosk); 1963 Jun; 41():38-43. PubMed ID: 14068990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of metabolism in patients with arteriosclerosis obliterans and arteritis].
    Savel'ev VS; Koshkin VM; Chesnokova TT; Endlina OV; Baranov AP
    Kardiologiia; 1988 Sep; 28(9):35-8. PubMed ID: 3236641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THROMBOANGIITIS OBLITERANS VERSUS ATHEROSCLEROSIS OBLITERANS.
    SELVAAG O; SIVERTSSEN E; SKANDSEN S; TROETTEBERG K
    J Oslo City Hosp; 1964 Jun; 14():97-111. PubMed ID: 14174922
    [No Abstract]   [Full Text] [Related]  

  • 18. Triglycerides and other lipid classes in human atherosclerosis.
    Ghirardi P; Marzo A; Brusoni B; Sardini D
    Experientia; 1972 Feb; 28(2):133-4. PubMed ID: 5020331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Observations on hematologic parameters in thromboangiitis obliterans of the blood stasis syndrome].
    Zheng P
    Zhong Xi Yi Jie He Za Zhi; 1986 Jun; 6(6):332-5, 323. PubMed ID: 2430727
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of thromboangiitis obliterans with clofibrate (Atromid-S).
    Cotton RC; Craven JL
    Angiology; 1968 May; 19(5):307-10. PubMed ID: 5656796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.